Drug Profile
RS 93427 007
Alternative Names: RS 93427Latest Information Update: 07 Nov 1997
Price :
$50
*
At a glance
- Originator Roche Palo Alto LLC
- Class Anti-ischaemics; Antihyperlipidaemics; Antithrombotics; Prostaglandins; Small molecules
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ischaemic heart disorders; Thrombosis
Most Recent Events
- 07 Nov 1997 No-Development-Reported for Ischaemic heart disorders in USA (Unknown route)
- 07 Nov 1997 No-Development-Reported for Thrombosis in USA (Unknown route)
- 24 Oct 1994 Preclinical development for Ischaemic heart disorders in USA (Unknown route)